论比较效果研究的局限性。 - Suppr

Suppr

超能文献

On the limitations of comparative effectiveness research.

作者信息

Rubin Donald B

机构信息

Department of Statistics, Harvard University, 1 Oxford Street, Cambridge, MA 02138, USA.

出版信息

Stat Med. 2010 Aug 30;29(19):1991-5; discussion 1996-7. doi: 10.1002/sim.3960.

DOI:10.1002/sim.3960

PMID:20683890

Abstract

摘要

相似文献

On the limitations of comparative effectiveness research.

Stat Med. 2010 Aug 30;29(19):1991-5; discussion 1996-7. doi: 10.1002/sim.3960.

The promise and realities of comparative effectiveness research.

Stat Med. 2010 Aug 30;29(19):1977-81; discussion 1996-7. doi: 10.1002/sim.3936.

What is evidence?

Stat Med. 2010 Aug 30;29(19):1985-8; discussion 1996-7. doi: 10.1002/sim.3933.

Revisiting issues, drawbacks and opportunities with observational studies in comparative effectiveness research.

J Eval Clin Pract. 2013 Aug;19(4):579-83. doi: 10.1111/j.1365-2753.2011.01802.x. Epub 2011 Nov 29.

The historical and moral imperatives of comparative effectiveness research.

Stat Med. 2010 Aug 30;29(19):1982-4; discussion 1996-7. doi: 10.1002/sim.3927.

Comparative effectiveness research: Policy context, methods development and research infrastructure.

Stat Med. 2010 Aug 30;29(19):1963-76. doi: 10.1002/sim.3818.

Facts, fallacies, and politics of comparative effectiveness research: Part I. Basic considerations.

Pain Physician. 2010 Jan-Feb;13(1):E23-54.

Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II.

Value Health. 2009 Nov-Dec;12(8):1053-61. doi: 10.1111/j.1524-4733.2009.00601.x. Epub 2009 Sep 10.

Comments on 'Comparative effectiveness research: Policy context, methods development and research infrastructure'.

Stat Med. 2010 Aug 30;29(19):1989-90; discussion 1996-7. doi: 10.1002/sim.3926.

Comparative effectiveness research - the missing link in evidence-informed clinical medicine and health care policy making.

Med J Aust. 2013 Apr 1;198(6):310-2. doi: 10.5694/mja12.10504.

引用本文的文献

Data to knowledge to improvement: creating the learning health system.

BMJ. 2024 Jan 25;384:e076175. doi: 10.1136/bmj-2023-076175.

Introduction to the special section "Reducing research waste in (health-related) quality of life research".

Qual Life Res. 2022 Oct;31(10):2881-2887. doi: 10.1007/s11136-022-03194-z.

Comparison of alternative approaches to trim subjects in the tails of the propensity score distribution.

Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1290-1298. doi: 10.1002/pds.4846. Epub 2019 Aug 5.

Assessing the incidence of acidosis in patients receiving metformin with and without risk factors for lactic acidosis.

Ther Adv Chronic Dis. 2018 Jun 13;9(9):179-190. doi: 10.1177/2040622318779760. eCollection 2018 Sep.

Use of Propensity Scores To Design Observational Comparative Effectiveness Studies.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw345.

Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw323.

Effect of a national requirement to introduce named accountable general practitioners for patients aged 75 or older in England: regression discontinuity analysis of general practice utilisation and continuity of care.

BMJ Open. 2016 Sep 16;6(9):e011422. doi: 10.1136/bmjopen-2016-011422.

Effect of Named, Accountable GPs on Continuity of Care: Protocol for a Regression Discontinuity Study of a National Policy Change.

Int J Integr Care. 2016 Mar 31;16(1):6. doi: 10.5334/ijic.2450.

A comparison of alternative strategies for choosing control populations in observational studies.

Health Serv Outcomes Res Methodol. 2015;15(3-4):157-181. doi: 10.1007/s10742-014-0135-8. Epub 2015 Jan 30.

Innovative Clinical Trial Designs: Toward a 21st-Century Health Care System.

Stat Biosci. 2011 Dec;3(2):145-168. doi: 10.1007/s12561-011-9042-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

On the limitations of comparative effectiveness research.

作者信息

Rubin Donald B

机构信息

Department of Statistics, Harvard University, 1 Oxford Street, Cambridge, MA 02138, USA.

出版信息

Stat Med. 2010 Aug 30;29(19):1991-5; discussion 1996-7. doi: 10.1002/sim.3960.

DOI:10.1002/sim.3960

PMID:20683890

Abstract

摘要

相似文献

On the limitations of comparative effectiveness research.

Stat Med. 2010 Aug 30;29(19):1991-5; discussion 1996-7. doi: 10.1002/sim.3960.

The promise and realities of comparative effectiveness research.

Stat Med. 2010 Aug 30;29(19):1977-81; discussion 1996-7. doi: 10.1002/sim.3936.

What is evidence?

Stat Med. 2010 Aug 30;29(19):1985-8; discussion 1996-7. doi: 10.1002/sim.3933.

Revisiting issues, drawbacks and opportunities with observational studies in comparative effectiveness research.

J Eval Clin Pract. 2013 Aug;19(4):579-83. doi: 10.1111/j.1365-2753.2011.01802.x. Epub 2011 Nov 29.

The historical and moral imperatives of comparative effectiveness research.

Stat Med. 2010 Aug 30;29(19):1982-4; discussion 1996-7. doi: 10.1002/sim.3927.

Comparative effectiveness research: Policy context, methods development and research infrastructure.

Stat Med. 2010 Aug 30;29(19):1963-76. doi: 10.1002/sim.3818.

Facts, fallacies, and politics of comparative effectiveness research: Part I. Basic considerations.

Pain Physician. 2010 Jan-Feb;13(1):E23-54.

Value Health. 2009 Nov-Dec;12(8):1053-61. doi: 10.1111/j.1524-4733.2009.00601.x. Epub 2009 Sep 10.

Comments on 'Comparative effectiveness research: Policy context, methods development and research infrastructure'.

Stat Med. 2010 Aug 30;29(19):1989-90; discussion 1996-7. doi: 10.1002/sim.3926.

Comparative effectiveness research - the missing link in evidence-informed clinical medicine and health care policy making.

Med J Aust. 2013 Apr 1;198(6):310-2. doi: 10.5694/mja12.10504.

引用本文的文献

Data to knowledge to improvement: creating the learning health system.

BMJ. 2024 Jan 25;384:e076175. doi: 10.1136/bmj-2023-076175.

Introduction to the special section "Reducing research waste in (health-related) quality of life research".

Qual Life Res. 2022 Oct;31(10):2881-2887. doi: 10.1007/s11136-022-03194-z.

Comparison of alternative approaches to trim subjects in the tails of the propensity score distribution.

Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1290-1298. doi: 10.1002/pds.4846. Epub 2019 Aug 5.

Assessing the incidence of acidosis in patients receiving metformin with and without risk factors for lactic acidosis.

Ther Adv Chronic Dis. 2018 Jun 13;9(9):179-190. doi: 10.1177/2040622318779760. eCollection 2018 Sep.

Use of Propensity Scores To Design Observational Comparative Effectiveness Studies.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw345.

Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw323.

BMJ Open. 2016 Sep 16;6(9):e011422. doi: 10.1136/bmjopen-2016-011422.

Effect of Named, Accountable GPs on Continuity of Care: Protocol for a Regression Discontinuity Study of a National Policy Change.

Int J Integr Care. 2016 Mar 31;16(1):6. doi: 10.5334/ijic.2450.

A comparison of alternative strategies for choosing control populations in observational studies.

Health Serv Outcomes Res Methodol. 2015;15(3-4):157-181. doi: 10.1007/s10742-014-0135-8. Epub 2015 Jan 30.

Innovative Clinical Trial Designs: Toward a 21st-Century Health Care System.

Stat Biosci. 2011 Dec;3(2):145-168. doi: 10.1007/s12561-011-9042-5.